The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Furosemide-Global Market Insights and Sales Trends 2025
Synopsis
Furosemide, sold under the brand name Lasix among others, is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.
The global Furosemide market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Furosemide in various end use industries. The expanding demands from the Hospital, Pharmacy, Clinics and Others, are propelling Furosemide market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Solution segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Furosemide market, driven by demand from China, the second largest economy with some signs of stabilising, the Furosemide market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Furosemide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Furosemide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Furosemide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Furosemide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Furosemide covered in this report include Sanofi Aventis, US Pharm Holdings, Mylan, Sandoz, Hospira, West-Ward Pharms, Ivax Sub Teva Pharms, Emcure Pharms and Sun Pharm Inds, etc.
The global Furosemide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Aventis
US Pharm Holdings
Mylan
Sandoz
Hospira
West-Ward Pharms
Ivax Sub Teva Pharms
Emcure Pharms
Sun Pharm Inds
Global Furosemide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Furosemide market, Segment by Type:
Injection
Solution
Tablet
Global Furosemide market, by Application
Hospital
Pharmacy
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Furosemide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Furosemide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Furosemide, sold under the brand name Lasix among others, is a medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease.
The global Furosemide market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Furosemide in various end use industries. The expanding demands from the Hospital, Pharmacy, Clinics and Others, are propelling Furosemide market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Solution segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Furosemide market, driven by demand from China, the second largest economy with some signs of stabilising, the Furosemide market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Furosemide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Furosemide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Furosemide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Furosemide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Furosemide covered in this report include Sanofi Aventis, US Pharm Holdings, Mylan, Sandoz, Hospira, West-Ward Pharms, Ivax Sub Teva Pharms, Emcure Pharms and Sun Pharm Inds, etc.
The global Furosemide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Aventis
US Pharm Holdings
Mylan
Sandoz
Hospira
West-Ward Pharms
Ivax Sub Teva Pharms
Emcure Pharms
Sun Pharm Inds
Global Furosemide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Furosemide market, Segment by Type:
Injection
Solution
Tablet
Global Furosemide market, by Application
Hospital
Pharmacy
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Furosemide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Furosemide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Furosemide Market Overview
1.1 Furosemide Product Overview
1.2 Furosemide Market Segment by Type
1.2.1 Injection
1.2.2 Solution
1.2.3 Tablet
1.3 Global Furosemide Market Size by Type
1.3.1 Global Furosemide Market Size Overview by Type (2018-2029)
1.3.2 Global Furosemide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Furosemide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Furosemide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Furosemide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Furosemide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Furosemide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Furosemide Sales Breakdown by Type (2018-2023)
2 Global Furosemide Market Competition by Company
2.1 Global Top Players by Furosemide Sales (2018-2023)
2.2 Global Top Players by Furosemide Revenue (2018-2023)
2.3 Global Top Players by Furosemide Price (2018-2023)
2.4 Global Top Manufacturers Furosemide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Furosemide Market Competitive Situation and Trends
2.5.1 Furosemide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Furosemide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Furosemide as of 2022)
2.7 Date of Key Manufacturers Enter into Furosemide Market
2.8 Key Manufacturers Furosemide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Furosemide Status and Outlook by Region
3.1 Global Furosemide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Furosemide Historic Market Size by Region
3.2.1 Global Furosemide Sales in Volume by Region (2018-2023)
3.2.2 Global Furosemide Sales in Value by Region (2018-2023)
3.2.3 Global Furosemide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Furosemide Forecasted Market Size by Region
3.3.1 Global Furosemide Sales in Volume by Region (2024-2029)
3.3.2 Global Furosemide Sales in Value by Region (2024-2029)
3.3.3 Global Furosemide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Furosemide by Application
4.1 Furosemide Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Clinics
4.1.4 Others
4.2 Global Furosemide Market Size by Application
4.2.1 Global Furosemide Market Size Overview by Application (2018-2029)
4.2.2 Global Furosemide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Furosemide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Furosemide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Furosemide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Furosemide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Furosemide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Furosemide Sales Breakdown by Application (2018-2023)
5 North America Furosemide by Country
5.1 North America Furosemide Historic Market Size by Country
5.1.1 North America Furosemide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Furosemide Sales in Volume by Country (2018-2023)
5.1.3 North America Furosemide Sales in Value by Country (2018-2023)
5.2 North America Furosemide Forecasted Market Size by Country
5.2.1 North America Furosemide Sales in Volume by Country (2024-2029)
5.2.2 North America Furosemide Sales in Value by Country (2024-2029)
6 Europe Furosemide by Country
6.1 Europe Furosemide Historic Market Size by Country
6.1.1 Europe Furosemide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Furosemide Sales in Volume by Country (2018-2023)
6.1.3 Europe Furosemide Sales in Value by Country (2018-2023)
6.2 Europe Furosemide Forecasted Market Size by Country
6.2.1 Europe Furosemide Sales in Volume by Country (2024-2029)
6.2.2 Europe Furosemide Sales in Value by Country (2024-2029)
7 Asia-Pacific Furosemide by Region
7.1 Asia-Pacific Furosemide Historic Market Size by Region
7.1.1 Asia-Pacific Furosemide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Furosemide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Furosemide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Furosemide Forecasted Market Size by Region
7.2.1 Asia-Pacific Furosemide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Furosemide Sales in Value by Region (2024-2029)
8 Latin America Furosemide by Country
8.1 Latin America Furosemide Historic Market Size by Country
8.1.1 Latin America Furosemide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Furosemide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Furosemide Sales in Value by Country (2018-2023)
8.2 Latin America Furosemide Forecasted Market Size by Country
8.2.1 Latin America Furosemide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Furosemide Sales in Value by Country (2024-2029)
9 Middle East and Africa Furosemide by Country
9.1 Middle East and Africa Furosemide Historic Market Size by Country
9.1.1 Middle East and Africa Furosemide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Furosemide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Furosemide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Furosemide Forecasted Market Size by Country
9.2.1 Middle East and Africa Furosemide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Furosemide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi Aventis
10.1.1 Sanofi Aventis Company Information
10.1.2 Sanofi Aventis Introduction and Business Overview
10.1.3 Sanofi Aventis Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Aventis Furosemide Products Offered
10.1.5 Sanofi Aventis Recent Development
10.2 US Pharm Holdings
10.2.1 US Pharm Holdings Company Information
10.2.2 US Pharm Holdings Introduction and Business Overview
10.2.3 US Pharm Holdings Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 US Pharm Holdings Furosemide Products Offered
10.2.5 US Pharm Holdings Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Furosemide Products Offered
10.3.5 Mylan Recent Development
10.4 Sandoz
10.4.1 Sandoz Company Information
10.4.2 Sandoz Introduction and Business Overview
10.4.3 Sandoz Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sandoz Furosemide Products Offered
10.4.5 Sandoz Recent Development
10.5 Hospira
10.5.1 Hospira Company Information
10.5.2 Hospira Introduction and Business Overview
10.5.3 Hospira Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hospira Furosemide Products Offered
10.5.5 Hospira Recent Development
10.6 West-Ward Pharms
10.6.1 West-Ward Pharms Company Information
10.6.2 West-Ward Pharms Introduction and Business Overview
10.6.3 West-Ward Pharms Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 West-Ward Pharms Furosemide Products Offered
10.6.5 West-Ward Pharms Recent Development
10.7 Ivax Sub Teva Pharms
10.7.1 Ivax Sub Teva Pharms Company Information
10.7.2 Ivax Sub Teva Pharms Introduction and Business Overview
10.7.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ivax Sub Teva Pharms Furosemide Products Offered
10.7.5 Ivax Sub Teva Pharms Recent Development
10.8 Emcure Pharms
10.8.1 Emcure Pharms Company Information
10.8.2 Emcure Pharms Introduction and Business Overview
10.8.3 Emcure Pharms Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Emcure Pharms Furosemide Products Offered
10.8.5 Emcure Pharms Recent Development
10.9 Sun Pharm Inds
10.9.1 Sun Pharm Inds Company Information
10.9.2 Sun Pharm Inds Introduction and Business Overview
10.9.3 Sun Pharm Inds Furosemide Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sun Pharm Inds Furosemide Products Offered
10.9.5 Sun Pharm Inds Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Furosemide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Furosemide Industrial Chain Analysis
11.4 Furosemide Market Dynamics
11.4.1 Furosemide Industry Trends
11.4.2 Furosemide Market Drivers
11.4.3 Furosemide Market Challenges
11.4.4 Furosemide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Furosemide Distributors
12.3 Furosemide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
